Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDL12
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,275
Award facts
- Contract value 100% obligated
- $98,274.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. The firm fixed-price delivery order, valued at $98,274.72, is scheduled for completion by September 5, 2025, and was issued on August 14, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, a $499.999 billion vehicle that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal pharmaceutical procurement market despite its woman-owned small business status.
Keytruda (pembrolizumab), an immunotherapy medication used primarily in oncology treatments, represents part of DLA's ongoing pharmaceutical supply requirements for Department of Defense healthcare operations. DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain, with a consistent portfolio of delivery orders covering oncology treatments, biologics, vaccines, and specialty medications. The firm's location in Park Ridge, Illinois serves as the place of performance for this delivery order, reinforcing the company's role in distributing critical pharmaceutical products to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FDL12?
SPE2DB25FDL12 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FDL12 worth?
The government has obligated $98,275 on SPE2DB25FDL12.
Is contract SPE2DB25FDL12 an order under another contract?
Yes. SPE2DB25FDL12 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL12 competed?
The extent of competition for SPE2DB25FDL12 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award